![SNGULAR integrates Navandu to strengthen its Health division](https://www.sngular.com/images/1/1671/hero_s/PostNavandu.webp)
SNGULAR integrates Navandu to strengthen its Health division
March 21, 2024
Navandu Technologies, a leading company in creating innovative digital products and services for professionals in the healthcare sector and the pharmaceutical industry, has joined the SNGULAR group, thus enhancing the capabilities of its SNGULAR HEALTH division.
SNGULAR is committed to developing this healthcare services, especially in the USA and other countries in the Americas, where there are opportunities and prospects for growth in pharmaceutical companies.
Fernando Rojas, founder and CEO of Navandu, becomes the new director of SNGULAR HEALTH, reporting directly to Raquel Araujo, Director of Business Development in the Americas.
According to Rojas, “Navandu has always pursued innovation in digital solutions that transform and redefine the relationship between the pharmaceutical industry and healthcare professionals.” With the launch of products like Tok medicine, it has “become a benchmark for disruption in the pharmaceutical industry, creating the first platform to offer technology for developing communities of doctors as a service and incorporating artificial intelligence in the search for scientific evidence”. For Navandu's founder, the integration with SNGULAR offers them the chance to “reach new horizons and expand our impact globally”.
Araujo stated that these solutions will help them “strengthen the positioning” of their technological capabilities as “business solutions in the healthcare sector and the pharmaceutical industry, further facilitating access to new clients.”
Finally, José Luis Vallejo, CEO of SNGULAR, said: “We are convinced that the incorporation of Navandu into SNGULAR HEALTH and the addition of Fernando and his team to our ecosystem, with all their industry know-how, will greatly enhance our activities in this sector.” For SNGULAR, this is a “strategic sector in the short to medium term, due to our company's interest in assisting healthcare companies, and because of the enormous potential of the latest technologies to adress various challenges in this industry”.
Our latest news
Interested in learning more about how we are constantly adapting to the new digital frontier?
![Unlocking the tech potential in international pharmaceutical tender management](https://www.sngular.com/images/1/1596/card/414x368/desbloqueando-el-potencial-de-market-explorer-en-la-gestion-internacional-de-licitaciones-farmaceuticas-2.webp)
Tech Insight
March 11, 2024
Unlocking the tech potential in international pharmaceutical tender management
![Pharmaceutical tenders: top 5 obstacles and how to overcome them](https://www.sngular.com/images/1/1241/card/414x368/licitaciones-farmaceuticas-los-5-principales-obstaculos-y-como-superarlos.webp)
Insight
January 18, 2024
Pharmaceutical tenders: top 5 obstacles and how to overcome them
![OYSHO Training, the evolution of a Leisure Brand to Activewear](https://www.sngular.com/images/1/1061/card/414x368/CartulaVdeoOysho.jpg)
Insight
November 26, 2023
OYSHO Training, the evolution of a Leisure Brand to Activewear